Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - tobramycin, quantity: 3 mg/ml - eye drops, solution - excipient ingredients: sodium chloride; boric acid; benzalkonium chloride; sodium hydroxide; tyloxapol; hydrochloric acid; sodium sulfate; purified water - tobrex(tobramycin) eye drops are topical antibiotics indicated in the treatment of external infections of the eye and its adnexa caused by susceptible bacteria. appropriate monitoring of bacterial response to topical antibiotic therapy should accompany the use of tobrex.

Israel - English - Ministry of Health

abic marketing ltd, israel - loteprednol etabonate; tobramycin - ophthalmic suspension - tobramycin 3 mg/ml; loteprednol etabonate 5 mg/ml - tobramycin - tobramycin - zylet is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists.ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, and where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns, or penetration of foreign bodies.the use of a combination drug with an anti-infective component is indicated where the risk of superficial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye.the particular anti-infective drug in this product (tobramycin) is active against the following common bacterial eye pathogens:staphylococci, including s. aureus and s. epidermidis (coagulase-positive and coagulase-negative), including penicillin-resistant strains. streptococci, including some of the group a-beta-hemolytic species, some nonhemolytic species, and some streptococcus pneumoniae. pseudomonas aeruginosa, escherichia coli, klebsiella pneumoniae, enterobacter aerogenes, proteus mirabilis, morganella morganii, most proteus vulgaris strains, haemophilus influenzae, and h. aegyptius, moraxella lacunata, acinetobacter calcoaceticus and some neisseria species.

Israel - English - Ministry of Health

novartis israel ltd - tobramycin - ophtalmic ointment - tobramycin 0.3 % - tobramycin - tobramycin - antibiotic for the treatment of eye infections caused by bacteria sensitive to tobramycin.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - ciprofloxacin hydrochloride, quantity: 3.5 mg/ml (equivalent: ciprofloxacin, qty 3 mg/ml) - eye drops, solution - excipient ingredients: benzalkonium chloride; mannitol; sodium hydroxide; purified water; hydrochloric acid; disodium edetate; glacial acetic acid; sodium acetate - treatment of bacterial keratitis (infected corneal ulcers) and severe bacterial conjunctivitis caused by organisms susceptible to ciprofloxacin in adults and children 12 months of age or older.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - ciprofloxacin hydrochloride, quantity: 3.5 mg/ml (equivalent: ciprofloxacin, qty 3 mg/ml) - eye drops, solution - excipient ingredients: sodium hydroxide; benzalkonium chloride; sodium acetate; glacial acetic acid; purified water; disodium edetate; hydrochloric acid; mannitol - treatment of bacterial keratitis (infected corneal ulcers) and severe bacterial conjuctivitis caused by organisms susceptible to ciprofloxacin. indications as at 25 july 1996: treatment of bacterial keratitis (infected corneal ulcers) and severe bacterial conjunctivitis caused by organisms susceptible to ciprofloxacin in adults and children 12 months of age or older.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - tobramycin 3 mg/ml - eye drops, solution - 0.3 % - active: tobramycin 3 mg/ml excipient: benzalkonium chloride boric acid purified water sodium chloride sodium hydroxide sodium sulfate sulfuric acid tyloxapol - tobrex eye drops and eye ointment are topical antibiotics indicated in the treatment of external infections of the eye and its adnexa caused by susceptible bacteria. appropriate monitoring of bacterial response to topical antibiotic therapy should accompany the use of tobrex.

Canada - English - Health Canada

apotex inc - tobramycin - solution - 0.3% - tobramycin 0.3% - antibacterials

Canada - English - Health Canada

sandoz canada incorporated - tobramycin - solution - 0.3% - tobramycin 0.3% - antibacterials

Malta - English - Medicines Authority

novartis ireland limited vista building, elm park, merrion road, ballsbridge, dublin 4,, ireland - tobramycin - eye ointment - tobramycin 3 mg/g - ophthalmologicals

Malta - English - Medicines Authority

novartis pharmaceuticals uk limited - tobramycin - eye drops, solution - tobramycin 3 mg/ml - ophthalmologicals